Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

All news

Show

From To
New HIV therapy reduces virus, boosts immunity in drug-resistant patients

A new HIV drug reduced viral replication and increased immune cells in individuals with advanced, drug-resistant HIV infection. Used in combination with existing HIV medications, the drug is a promising strategy for patients who have run out of effective treatment options, the researchers said.

Published
2 hours ago
From
Science Daily
One in nine people may be able to control their viral load after stopping treatment, US study finds

A US collaboration that pooled data from 14 scientific studies containing between them more than 600 HIV-positive people has found that 67 of them were able to

Published
3 hours ago
By
Gus Cairns
People taking a protease inhibitor who have heart failure have an increased mortality risk, study claims

HIV-positive people who are taking antiretroviral therapy (ART) and are hospitalised due to heart failure are more likely to die because of cardiovascular disease if they are taking

Published
4 hours ago
By
Michael Carter
Privilege and Profit Corrupt the PrEP Access Debate

If most folks are getting their PrEP for free, then who cares what Gilead charges? Peter Staley explains why ALL of us should care.

Published
15 August 2018
From
Poz
South Africa: Almost half of injecting drug users surveyed have contracted Hepatitis C

Close to half of injecting drug users surveyed in South Africa are living with the potentially deadly Hepatitis C virus, a new study has found. But a drug that could cure them, and that is used in several countries, remains unavailable in South Africa.

Published
15 August 2018
From
Bhekisisa
ViiV, Janssen’s two-drug HIV regimen hits PhIII targets

ViiV Healthcare and Janssen have unveiled positive headline data from a late-stage trial of their injectable two-drug regimen for the treatment of HIV.

Published
15 August 2018
From
Pharma Times
Lynne Mofenson, M.D., Explains the Dolutegravir Risks for People With HIV Who Want to Get Pregnant

Lynn Mofenson, M.D., who is a researcher with the Elizabeth Glaser Pediatric AIDS Foundation, explains what is known about the potential risk of neural tube defects when dolutegravir is used around the time of conception.

Published
15 August 2018
From
The Body PRO
Medical male circumcision: is the HIV prevention claim wrong?

Circumcision is a proven intervention that reduces the chance of contracting HIV by 60%, but to scientists’ surprise, a study has found that medically circumcised older men in Mpumalanga had a higher rate of HIV than uncircumcised men.

Published
15 August 2018
From
Business Day
People taking HIV-prevention pill may get more primary care

When people take daily pills to minimize their chances of getting HIV, they are also more likely to get routine care like flu shots and recommended screenings for common health problems, a U.S. study suggests.

Published
15 August 2018
From
Reuters
Sometimes Nice Guys Finish First: Preferences for HIV Care in Zambia

As a healthcare patient, what would you sacrifice for a provider with a nice—rather than rude—attitude? For HIV patients in Zambia, the answer may surprise you. According to findings of a study published August 13, 2018, in PLOS Medicine, HIV patients in Zambia were willing to increase wait time and travel distance—and accept significant reduction in medication—in order to access a healthcare provider with a nice attitude.

Published
15 August 2018
From
UCSF News Services
← First12345...2472Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.